0001493152-23-000424.txt : 20230104 0001493152-23-000424.hdr.sgml : 20230104 20230104205810 ACCESSION NUMBER: 0001493152-23-000424 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230103 FILED AS OF DATE: 20230104 DATE AS OF CHANGE: 20230104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gottschalk Emily CENTRAL INDEX KEY: 0001791108 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37492 FILM NUMBER: 23509508 MAIL ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY STREET 2: SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Anixa Biosciences Inc CENTRAL INDEX KEY: 0000715446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112622630 STATE OF INCORPORATION: DE FISCAL YEAR END: 1031 BUSINESS ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 BUSINESS PHONE: 408-708-9808 MAIL ADDRESS: STREET 1: 3150 ALMADEN EXPRESSWAY, SUITE 250 CITY: SAN JOSE STATE: CA ZIP: 95118 FORMER COMPANY: FORMER CONFORMED NAME: ITUS Corp DATE OF NAME CHANGE: 20140902 FORMER COMPANY: FORMER CONFORMED NAME: COPYTELE INC DATE OF NAME CHANGE: 19920703 4 1 ownership.xml X0306 4 2023-01-03 0 0000715446 Anixa Biosciences Inc ANIX 0001791108 Gottschalk Emily C/O ANIXA BIOSCIENCES, INC. 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE, CA 95118 1 0 0 0 Employee Stock Option (Right to Buy) 4.19 2023-01-03 4 A 0 25000 0 A 2033-01-03 Common Stock 25000 25000 D Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan. The options vest and become exercisable in twelve (12) equal monthly installments beginning January 31, 2023. /s/ Emily Gottschalk 2023-01-04